QB3 Central WebsiteQB3-Berkeley | QB3-UCSC | QB3-UCSF


Quick Links

» Stanley Facility
Support

» Stanley Room Reservations

» Core Research Facilities

» QB3 Garage

» Research Enterprise Services (RES)

» UC Berkeley Directory


Follow QB3

Twitter    YouTube

Make a Gift

Twitter


In the Media

4/10 Chemistry World
Yeast to make malaria drug on demand

3/19 Forbes
This protein could change biotech forever

3/12 The Atlantic
The sequester is going to devastate U.S. science research for decades

3/12 Nature
DNA tool kit goes live online

3/6 Daily Mail
Did life on Earth arrive on a comet?

2/28 PBS: Nova
Why synthetic biology is the field of the future


News & Events

Turning up the heat on biofuels

Trichoderma reesei EGI

Production of biofuels from lignocellulosic biomass would benefit on several levels if carried out at temperatures between 65 and 70 degrees Celsius. Douglas Clark and his colleagues have employed a promising technique for improving the ability of cellulase enzymes to operate at advantageously high temperatures. More >




Michael Rape
Rape appointed HHMI Investigator
Michael Rape’s experiments at age 12 on how air pollution killed trees in his native Bavaria, eventually led him to a career studying the impacts of chemicals on biology. His current work on a protein, ubiquitin, found in every cell in the body has gained him an appointment as a Howard Hughes Medical Institute (HHMI) investigator. More >


James Berger
Berger named to National Academy of Sciences
Biochemist and structural biologist James Berger has been elected member of the National Academy of Sciences (NAS), one of the highest honors given to a scientist or engineer in the United States. He has been recognized for elucidating the structures of topoisomerases and helicases and providing insights into the biochemical mechanisms that mediate the replication and transcription of DNA. More >


Telomerase enzyme
Scientists map elusive 3-D structure of telomerase enzyme, key actor in cancer, aging
Like finally seeing all the gears of a watch and how they work together, Kathleen Collins and her colleagues have, for the first time ever, solved the puzzle of how the various components of an entire telomerase enzyme complex fit together and function in a three-dimensional structure. The research represents a breakthrough that could open up a host of new approaches to fighting disease. More >


Artemisinin
Launch of antimalarial drug a triumph for synthetic biology
The best therapy today for malaria is a drug combination that includes a derivative of artemisinin, now solely available from plants. On April 11, Sanofi began production of the first semi-synthetic version of artemisinin, derived from yeast developed by biotech company Amyris based on discoveries in the laboratory of Jay Keasling. More >

More News >


Noteworthy

Michelle Chang

Chang honored
Michelle Chang has won two young faculty awards – a Camille Dreyfus Teacher-Scholar Award and a 3M Nontenured Faculty Award. More>

Douglas Clark

Clark tapped for deanship
Douglas Clark, chair of Chemical and Biomolecular Engineering, has been designated the new dean of the College of Chemistry. More >

Lydia Sohn

A tested career path
Lydia Sohn’s constant optimism belies the challenges she has faced, not only as a whistle-blower in a data- fabrication scandal, but also through her decisions to constantly shift fields of study. More >

Calendar   QB3 Berkeley Calendar

Tue 5/28 12:30pm
Role for Mg2+ in lymphocyte signaling revealed by XMEN disease – a new primary immunodeficiency

Wed 5/29 9am
Genetics, Development and Molecular Evolution Supergroup Symposium

Thu 5/30 9am
UCSC Stem Cells and Aging Symposium

Full Calendar >